However, this assumption has not yet been experimentally confirmed—only an increase in NT-4 serum concentration was established in bipolar disorder (Loch et al., 2015), but not in schizophrenia (Skibinska et al., 2019). This evidence concerns the gene NTF4 and schizophrenia.